TY - JOUR
T1 - Investigations on the 4-Quinolone-3-Carboxylic Acid Motif Part 5
T2 - Modulation of the Physicochemical Profile of a Set of Potent and Selective Cannabinoid-2 Receptor Ligands through a Bioisosteric Approach
AU - Mugnaini, Claudia
AU - Nocerino, Stefania
AU - Pedani, Valentina
AU - Pasquini, Serena
AU - Tafi, Andrea
AU - De Chiaro, Maria
AU - Bellucci, Luca
AU - Valoti, Massimo
AU - Guida, Francesca
AU - Luongo, Livio
AU - Dragoni, Stefania
AU - Ligresti, Alessia
AU - Rosenberg, Avraham
AU - Bolognini, Daniele
AU - Cascio, Maria Grazia
AU - Pertwee, Roger G
AU - Moaddel, Ruin
AU - Maione, Sabatino
AU - Di Marzo, Vincenzo
AU - Corelli, Federico
N1 - Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2012/5
Y1 - 2012/5
N2 - Three heterocyclic systems were selected as potential bioisosteres of the amide linker for a series of 1,6-disubstituted-4-quinolone-3-carboxamides, which are potent and selective CB2 ligands that exhibit poor water solubility, with the aim of improving their physicochemical profile and also of clarifying properties of importance for amide bond mimicry. Among the newly synthesized compounds, a 1,2,3-triazole derivative (1-(adamantan-1-yl)-4-[6-(furan-2-yl)-1,4-dihydro-4-oxo-1-pentylquinolin-3-yl]-1H-1,2,3-triazole) emerged as the most promising in terms of both physicochemical and pharmacodynamic properties. When assayed in vitro, this derivative exhibited inverse agonist activity, whereas, in the formalin test in mice, it produced analgesic effects antagonized by a well-established inverse agonist. Metabolic studies allowed the identification of a side chain hydroxylated derivative as its only metabolite, which, in its racemic form, still showed appreciable CB2 selectivity, but was 150-fold less potent than the parent compound.
AB - Three heterocyclic systems were selected as potential bioisosteres of the amide linker for a series of 1,6-disubstituted-4-quinolone-3-carboxamides, which are potent and selective CB2 ligands that exhibit poor water solubility, with the aim of improving their physicochemical profile and also of clarifying properties of importance for amide bond mimicry. Among the newly synthesized compounds, a 1,2,3-triazole derivative (1-(adamantan-1-yl)-4-[6-(furan-2-yl)-1,4-dihydro-4-oxo-1-pentylquinolin-3-yl]-1H-1,2,3-triazole) emerged as the most promising in terms of both physicochemical and pharmacodynamic properties. When assayed in vitro, this derivative exhibited inverse agonist activity, whereas, in the formalin test in mice, it produced analgesic effects antagonized by a well-established inverse agonist. Metabolic studies allowed the identification of a side chain hydroxylated derivative as its only metabolite, which, in its racemic form, still showed appreciable CB2 selectivity, but was 150-fold less potent than the parent compound.
KW - bioisosteres
KW - cannabinoids
KW - quinolones
KW - receptors
KW - structure-activity relationship
U2 - 10.1002/cmdc.201100573
DO - 10.1002/cmdc.201100573
M3 - Article
C2 - 22383251
VL - 7
SP - 920
EP - 934
JO - ChemMedChem
JF - ChemMedChem
SN - 1860-7179
IS - 5
ER -